Focalin Xr(Dexmethylphenidate Hcl)
Medicare prescription drug cost, prescriptions and prescribers, 2024
$1.1M
Medicare cost, 2024
$1.1M
Medicare cost, 2024
Medicare drug plans spent $1.1 million on Focalin Xr (dexmethylphenidate hcl) in 2024, for 3,831 prescriptions and refills filled by 936 patients. Spending fell 44% from 2023 to 2024. Wisconsin accounts for the most spending ($96,003, 9% of the total).
Medicare cost, 2024
$1.1M
-43.6% from 2023
Prescriptions
3,831
$276.57 per claim
Patients
936
1,136 prescribers
Total spending, 2024
$1.1M
$1,132.71 per patient
Questions and answers
How much does Medicare spend on Focalin Xr?
Medicare prescription drug plans paid $1.1M for Focalin Xr in 2024, for 3,831 prescriptions and refills to 936 patients (down 43.6% from 2023). The average cost per claim was $276.57.
Which state spends the most on Focalin Xr?
Wisconsin had the highest Medicare cost for Focalin Xr in 2024: $96K for 327 claims, followed by New York ($84K).
Who prescribes Focalin Xr the most?
Patricia McGoldrick, nurse practitioner in Hawthorne, NY, had the highest Medicare cost for Focalin Xr in 2024: 22 claims costing $10K.
Spending over the years
Medicare spending by year
All plans and makers
Prescriber data: cost by year
Medicare spending on Focalin Xr was $1.1M in 2024, after a high of $1.9M in 2023.
By state
Where the prescribers practice, 2024
Medicare cost by state
States with the highest cost
Top prescribers of Focalin Xr, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Patricia McGoldrick Hawthorne, NY | Nurse Practitioner | 22 | Under 11 | $10K |
| Lisa A Ryan Chicago, IL | Internal Medicine | 43 | Under 11 | $9,221 |
| Stanley Fudala Fort Atkinson, WI | Psychiatry | 23 | Under 11 | $7,936 |
| Michael R Vicente Oshkosh, WI | Psychiatry | 13 | Under 11 | $7,757 |
| Natalie A Snow Albany, NY | Nurse Practitioner | 22 | Under 11 | $7,747 |
| Colleen M Zanis Rockville, MD | Psychiatry | 22 | Under 11 | $7,690 |
| Barbara M D'Orio Watkinsville, GA | Psychiatry | 11 | Under 11 | $6,446 |
| Delvis A Celdran Port Saint Lucie, FL | Neurology | 12 | Under 11 | $6,345 |
| John E Gallehr Louisville, KY | Pediatric Medicine | 15 | Under 11 | $5,903 |
| Joseph Carmody New York, NY | Psychiatry | 24 | Under 11 | $5,475 |
| Chris E McGee Decatur, TX | Family Practice | 11 | Under 11 | $5,215 |
| Craig C Benson II Bucksport, ME | General Practice | 11 | Under 11 | $5,101 |
| Derek C Carlson Green Bay, WI | Psychiatry | 12 | Under 11 | $5,053 |
| Audrey Griesbach Los Angeles, CA | Pediatric Medicine | 13 | Under 11 | $5,025 |
| Ruth A Raczkowski Mattapan, MA | Nurse Practitioner | 15 | Under 11 | $4,867 |
| Christopher M Gakwa Boise, ID | Nurse Practitioner | 20 | Under 11 | $4,743 |
| Frank S Floca Austin, TX | Psychiatry | 18 | Under 11 | $4,539 |
| Branislav Stojanovic Dania Beach, FL | Psychiatry & Neurology | 13 | Under 11 | $4,516 |
| Mitchell Pulver Brunswick, ME | Psychiatry | 12 | Under 11 | $4,492 |
| Daniel Suter New York, NY | Psychiatry | 18 | Under 11 | $4,260 |
| Eleni Hailemariam Orange, CA | Psychiatry | 23 | Under 11 | $4,106 |
| Ariye M Krassner Willimantic, CT | Nurse Practitioner | 18 | Under 11 | $3,848 |
| Ericka M Distefano Gwinn, MI | Nurse Practitioner | 19 | Under 11 | $3,749 |
| Matthew Malone Las Vegas, NV | Student in an Organized Health Care Education/Training Program | 11 | Under 11 | $3,725 |
| Darrin S Friesen Saint Louis, MO | Specialist | 14 | Under 11 | $3,652 |
Prescriber data by year
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 616 | 2,624 | 487 | $1.4M |
| 2023 | 955 | 3,482 | 799 | $1.9M |
| 2024 | 1,136 | 3,831 | 936 | $1.1M |
Makers, 2024
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Novartis/Sandoz | 3,825 | $1.1M |
| Sandoz Inc. | 23 | $5,140 |
Medicaid spending by quarter
Amount reimbursed by state Medicaid programs, all states
Amount reimbursed
Codes
- National drug codes (packages)
- 18
- RxNorm concept IDs
- 1006608, 1006610, 1101926, 1101928, 1101932
- Application numbers
- NDA021802
More drugs: Medicare drug spending and the Prescriptions view.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
Through September 2026, 5,016 side-effect reports named dexmethylphenidate hydrochloride, the active ingredient of Focalin Xr (reports from 2004 on). 1,695 of them (33.8%) were serious, 36 named a death and 438 named a hospital stay. The reactions named most often were drug ineffective, anxiety and nausea. 1,986 reports came in the last 5 years (since 2022).
How to read these numbers
- A report shows that a patient, doctor or drug company suspected a link. It does not prove that the drug caused the effect.
- Counts are not risk rates. They depend on how many people use the drug, how long it has been sold, news and reporting habits, so they do not show which drug is safer.
- The newest months are partial: reports keep arriving late.
Reports, all years
5,016
411 in 2025 (+14.2% from 2024)
Serious
33.8%
1,695 reports
Deaths named
36
0.7% of reports
Hospital stays
438
8.7% of reports
Reports by year
Serious reports include those that name a death, a hospital stay, a disability or another serious outcome.
Reports received by year
2026 is the year so far.
Reports naming a death or a hospital stay
One report can name both
Reactions
Reactions named most often
All years. Share = part of all reports in that period. A report can name several reactions.
Patients
As given in the reports; many reports leave sex or age out.
Sex of the patient
All years
Age of the patient
Age when the effect started, all years
Questions and answers
How many side-effect reports name Focalin Xr?
5,016 reports from 2004 through September 2026 named dexmethylphenidate hydrochloride, the active ingredient of Focalin Xr. 1,695 of them (33.8%) were serious, 36 named a death and 438 named a hospital stay.
What are the most reported side effects of Focalin Xr?
859 reports named drug ineffective, the reaction named most often, followed by anxiety (241) and nausea (240). In the last 5 years the reaction named most often was drug ineffective (371 reports). A report can name several reactions.
How many side-effect reports named Focalin Xr in 2025?
411 reports were received in 2025 (+14.2% from 2024). 2026 so far: 315 reports through September 2026, and more keep arriving late.
Do side-effect reports prove that Focalin Xr caused a problem?
No. A report shows that a patient, doctor or drug company suspected a link; it does not prove that Focalin Xr caused the effect. Report counts depend on how widely a drug is used, how long it has been sold, news and reporting habits, so they are not risk rates and do not show which drug is safer.
Related pages
- Other Medicare drug pages with dexmethylphenidate hydrochloride: Focalin
- Drug approvals (2 approvals on file for dexmethylphenidate hydrochloride) · Clinical trials · Medicare drug spending
Side-effect reports from official public data, counted per active ingredient (dexmethylphenidate hydrochloride) by the year the report was received, so the brand and generic pages of one ingredient show the same reports. A report can name several drugs and several reactions and counts for each. Reaction names are the standard medical terms used in the reports. Reports whose product could not be matched to a drug are not counted. Updated November 2026.